US venture capital provider Battelle Ventures has spun
out regenerative medicine start-up company NellOne Therapeutics from the
US Department of Energy's Oak Ridge National
Laboratory.
by Eisberg, Neil
US venture capital provider Battelle Ventures has spun out
regenerative medicine start-up company NellOne Therapeutics from the US
Department of Energy's Oak Ridge National Laboratory. The new
company will specialise in the development of protein therapeutics with
the potential to restore tissue mass and function after a heart attack.
COPYRIGHT 2008 Society of Chemical
Industry Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.